TickerFactsScreenerDevelopers

Arcus Biosciences, Inc. (RCUS) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2015: $46.87M2016: $65.16M2017: $98.43M2018: $71.06M2019: $57.94M2020: $173.41M2021: $148.00M2022: $206.00M2023: $127.00M2024: $150.00M2025: $222.00M$222.00M
2015Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$222.00M+48.0%
2024$150.00M+18.1%
2023$127.00M-38.3%
2022$206.00M+39.2%
2021$148.00M-14.7%
2020$173.41M+199.3%
2019$57.94M-18.5%
2018$71.06M-27.8%
2017$98.43M+51.1%
2016$65.16M+39.0%
2015$46.87M—